What is RadNet's market cap?

RadNet (RDNT) has a market capitalization of $4.8B and trades on NASDAQ.

What is RadNet's revenue and profitability?

RadNet generated $2.1B in trailing twelve-month revenue with a net loss of $14.2M, representing a net margin of -0.7%. Gross margin stands at 13.4%, with free cash flow of $109.6M. These figures are based on the Q1 2026 filing.

Who are RadNet's competitors?

RadNet's key competitors include Lumexa Imaging Holdings, Inc. Common Stock, GE HealthCare Technologies Inc. Common Stock, QT Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does RadNet partner with?

RadNet's notable partners include GE HealthCare, Hologic, Philips, and others.

What subsidiaries does RadNet have?

RadNet's subsidiaries include DeepHealth, Inc., eRad, Inc., Aidence Holding B.V., and others.

Where is RadNet headquartered?

RadNet is headquartered in United States of America and employs approximately 10,288 people. It has been publicly traded since 1994.

RadNet

RDNT

RadNet is a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States.

Market cap

$4.84B+11.0%

Revenue$2.1B+14.7%

Net income-$14.2M+56.1%

Free cash flow$109.6M+40.0%

EPS (diluted)-$0.18+58.1%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 11, 2026

Revenue$575.6MBeat by $17.7M EPS-$0.28Miss by $0.14

Read the full report

Next report

Aug 9, 2026 (In 1 week)

Revenue estimate$610.0M

EPS estimate$0.18

Financials

Q1 2026

Income statement

See full

Revenue$575.6M+22.1%

Operating income-$23.9M+0.8%

Net income-$33.5M+11.8%

EPS (diluted)-$0.43+15.7%

Balance sheet

See full

Cash & equivalents$455.3M-36.5%

Total debt$1.9B+10.8%

Total equity$1.1B+20.3%

Total assets$3.9B+16.5%

Cash flow

See full

Operating cash flow$79.0M+90.4%

CapEx$69.9M+43.2%

Free cash flow$9.0M+223%

Valuation & ratios

Valuation

See full

Market cap$4.84B+11.0%

Enterprise value$6.32B+15.8%

P/S2.3×-0.1×

Profitability

See full

Operating margin2.9%-0.8pp

Net margin-0.7%-0.3pp

FCF margin5.1%+0.9pp

Returns & leverage

See full

Return on equity-1.4%-0.5pp

Debt / equity1.8×-0.2×

Current ratio1.2×-0.8×

Segments

By product

See full

Commercial insurance$315.9M+20.3%

Medicare$137.2M+26.8%

Other payors$33.6M+21.3%

Revenue under capitation arrangements$30.4M-5.1%

Other revenue$24.8M+97.8%

By segment

See full

Imaging Center$556.8M+20.7%

Digital health$29.1M+51.5%

Competitors

By market cap

GE HealthCare Technologies$27.8B-21.9%

RadNet$4.8B+8.8%

iRadimed$1.2B+67.4%

Lumexa Imaging Holdings, Inc. $1.1B—

Varex Imaging Corporation$462.8M+41.1%

Hyperfine, Inc.$95.3M+11.4%

QT Imaging Holdings, Inc.$37.3M—

OneMedNet$34.5M+49.7%

By revenue growth

QT Imaging Holdings, Inc.+259%

Hyperfine, Inc.+30.7%

iRadimed+14.8%

RadNet+14.7%

GE HealthCare Technologies+6.5%

Varex Imaging Corporation+3.6%

By net margin

iRadimed27.36%+1.0pp

GE HealthCare Technologies9.33%-1.9pp

RadNet-0.662%+1.1pp

Varex Imaging Corporation-16.26%-4.4pp

QT Imaging Holdings, Inc.-58.94%+250pp

Hyperfine, Inc.-226.88%+117pp

Profile

RadNet is a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates a vast network of imaging centers and provides a comprehensive suite of non-invasive diagnostic procedures to facilitate the diagnosis and treatment of diseases. Its value proposition is centered on a multi-modality strategy, regional market density, and the integration of advanced artificial intelligence to enhance clinical interpretation and operational efficiency.

Competitive position

RadNet is the largest operator of freestanding outpatient diagnostic imaging centers in the U.S. based on center count and revenue, leveraging significant scale and regional density.

GeographiesUnited States, United Kingdom, Netherlands

Customer segmentsPatients, Healthcare Providers, Insurance Payors, Government Agencies

Business modelFee-for-service, Capitation, B2B Software Sales, Joint Venture

SuppliersMedical Imaging Equipment Manufacturers, Radiopharmaceutical Suppliers, Cloud Infrastructure Providers, Medical Supply Vendors

CustomersReferring Physicians, Health Insurance Payors, Hospital Systems, Patients

CountryUnited States of America

Listed1994

Employees10.3K

CEOHoward G. Berger

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websiteradnet.com

FilingsSEC EDGAR

Ask your AI about RadNet.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is RadNet's market cap?: RadNet (RDNT) has a market capitalization of $4.8B and trades on NASDAQ.
What is RadNet's revenue and profitability?: RadNet generated $2.1B in trailing twelve-month revenue with a net loss of $14.2M, representing a net margin of -0.7%. Gross margin stands at 13.4%, with free cash flow of $109.6M. These figures are based on the Q1 2026 filing.
Who are RadNet's competitors?: RadNet's key competitors include Lumexa Imaging Holdings, Inc. Common Stock, GE HealthCare Technologies Inc. Common Stock, QT Imaging Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does RadNet partner with?: RadNet's notable partners include GE HealthCare, Hologic, Philips, and others.
What subsidiaries does RadNet have?: RadNet's subsidiaries include DeepHealth, Inc., eRad, Inc., Aidence Holding B.V., and others.
Where is RadNet headquartered?: RadNet is headquartered in United States of America and employs approximately 10,288 people. It has been publicly traded since 1994.